Isolated BCSC from the three major breast cancer molecular subtypes, i.e. ER+, HER2 and triple negative, exhibit an Orai and TRPC channel expression signature that, as compared to BSC derived from non-tumoral breast epithelial cells, qualitatively differs from their expression in differentiated cancer cells of the same subtype. This evidence concerns the gene ERBB2 and breast cancer.